(Q52936283)

English

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

1 reference

based on heuristic

inferred from title

reproducibility

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Tsuda H

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Akiyama F

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Terasaki H

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Hasegawa T

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Kurosumi M

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Shimadzu M

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Yamamori S

7

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Sakamoto G

8

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

92

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

12

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

2965-2974

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Concordance in judgments among c-erbB-2 (HER2/neu) overexpression detected by two immunohistochemical tests and gene amplification detected by Southern blot hybridization in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

A Coefficient of Agreement for Nominal Scales

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C2965%3A%3AAID-CNCR10156%3E3.0.CO%3B2-A

21 January 2018

Identifiers

10.1002/1097-0142(20011215)92:12<2965::AID-CNCR10156>3.0.CO;2-A

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

release_ylhanihc2vec3eggahhsqtbu4y

1 reference

https://api.fatcat.wiki/v0/release/ylhanihc2vec3eggahhsqtbu4y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11753973

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52936283&oldid=2165612684"